1.Cox CD, Breslin MJ, Mariano BJ, Coleman PJ, Buser CA, Walsh ES, Hamilton K, Huber HE, Kohl NE, Torrent M, Yan Y, Kuo LC, Hartman GD.. (2005) Kinesin spindle protein (KSP) inhibitors. Part 1: The discovery of 3,5-diaryl-4,5-dihydropyrazoles as potent and selective inhibitors of the mitotic kinesin KSP., 15 (8):[PMID:15808464][10.1016/j.bmcl.2005.02.055]
2.Lv PC, Sun J, Luo Y, Yang Y, Zhu HL.. (2010) Design, synthesis, and structure-activity relationships of pyrazole derivatives as potential FabH inhibitors., 20 (15):[PMID:20594840][10.1016/j.bmcl.2010.05.105]
3.PubChem BioAssay data set,
4.Nepali K, Singh G, Turan A, Agarwal A, Sapra S, Kumar R, Banerjee UC, Verma PK, Satti NK, Gupta MK, Suri OP, Dhar KL.. (2011) A rational approach for the design and synthesis of 1-acetyl-3,5-diaryl-4,5-dihydro(1H)pyrazoles as a new class of potential non-purine xanthine oxidase inhibitors., 19 (6):[PMID:21353569][10.1016/j.bmc.2011.01.058]
5.Nepali K, Kadian K, Ojha R, Dhiman R, Garg A, Singh G, Buddhiraja A, Bedi PMS, Dhar KL. (2012) Effect of ring A and ring B substitution on the cytotoxic potential of pyrazole tethered chalcones, 21 (10):[10.1007/s00044-011-9824-9]
6.Raghav N, Singh M.. (2014) SAR studies of differently functionalized chalcones based hydrazones and their cyclized derivatives as inhibitors of mammalian cathepsin B and cathepsin H., 22 (15):[PMID:24913985][10.1016/j.bmc.2014.05.037]
